According to the research report titled ‘Europe Rare Sugar Market Size By Application, By Product, Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2020 – 2026’, available with Market Study Report, Europe rare sugar market is anticipated to record a strong compound annual growth rate through 2026.
 

Changing eating preferences, growing consumer spending, and widespread adoption of calorie deficient ingredients and sugar alternatives in diets are some of the major factors fueling the growth of Europe rare sugar market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3959219/
 

Additionally, increasing instances of chronic diseases has resulted in extensive usage of dietary supplements, sugar alternatives, and low sugar products in order to live a healthier lifestyle, which in turn is propelling the market scenario in Europe.
 

In terms of product gamut, the industry outlook is bifurcated into Allulose, D-Xylose, L-Fucose, D-Mannose, L-Arabinose and Tagatose. The D-Mannose segment was valued at USD 120 million in 2019 and is slated to grow consistently during the analysis timeframe, owing to rising demand of nutritional supplements to enhance urinary tract health and available of various treatment options.
 

On the other hand, the Allulose segment is poised to grow with a CAGR of over 6.5% through 2026. Factors like surging number of obese and diabetes patients opting for low calorie sweeteners, rising adoption of the product in food as a sugar substitutes and rising cognizance regarding chronic ailments, diet and health are catalyzing the growth of Europe rare sugar market from the allulose segment.
 

Based on application scope, Europe rare sugar market space is classified into cosmetics & personal care, pharmaceuticals, food & beverages, dietary supplements and others. The dietary supplements segment surpassed USD 75 million in 2019 and is anticipated to flourish rapidly over the forecast duration, accredited to large number of diabetes patients and increasing consumer awareness.
 

Regionally, Germany rare sugar industry has been showcasing immense growth and is expected to grow further through 2026, creditable to rising prevalence of chronic diseases like cardiovascular diseases and hypertension as well as high consumer awareness towards maintaining healthy lifestyle.
 

Some of the leading companies in Europe rare sugar industry sphere are Bonumose Inc., DuPont de Nemours Inc., Zhangjiagang Specom Biochemical Co. Ltd., The Sanwa Starch Co., Ltd., Matsutani Chemical Industry Co. Ltd., Ingredion Incorporated, Douglas Laboratories Europe B.V., Nutraceuticals Group, Samyang Corporation, Tate & Lyle PLC, and Sweet Cures.